Literature DB >> 6369666

Recurrence of autoimmune chronic active hepatitis following orthotopic liver grafting.

J Neuberger, B Portmann, R Calne, R Williams.   

Abstract

In a 26-year-old woman who had received an orthotopic liver graft for end-stage autoimmune chronic active hepatitis, signs indicative of the original disease became apparent 18 months after transplantation, at a time when the maintenance dose of prednisolone had been reduced to 3 mg daily. In addition to anorexia, nausea, and weight loss there was a reappearance of spider naevi, serum autoantibodies, and elevated levels of immunoglobulin G. Features typical of chronic active hepatitis were observed on examination of the liver biopsy, and both the clinical and histological pictures were unlike those of other possible causes of liver dysfunction, such as chronic rejection, cyclosporine hepatotoxicity, and non-A non-B chronic hepatitis. Following substitution of azathioprine for cyclosporine and an increased dose of prednisolone (20 mg daily), there was a rapid improvement in the clinical state and both serum transaminases and immunoglobulins returned to normal values. Histological appearances in a repeat biopsy taken six months later were consistent with chronic active hepatitis in remission. This case provides further evidence of the importance of host factors in the pathogenesis of chronic active hepatitis and emphasizes the necessity for selecting appropriate immunosuppressive therapy in such patients after transplantation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6369666     DOI: 10.1097/00007890-198404000-00009

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  19 in total

Review 1.  Liver transplantation.

Authors:  J G O'Grady; B Portmann
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

2.  Liver transplantation in the adult.

Authors:  R Y Calne; R Williams; K Rolles
Journal:  World J Surg       Date:  1986-06       Impact factor: 3.352

Review 3.  Autoimmune Hepatitis: Surviving Crises of Doubt and Elimination.

Authors:  Albert J Czaja
Journal:  Clin Liver Dis (Hoboken)       Date:  2020-03-02

Review 4.  Autoimmune Hepatitis in the Liver Transplant Graft.

Authors:  Eliza W Beal; Sylvester M Black; Anthony Michaels
Journal:  Clin Liver Dis       Date:  2017-05       Impact factor: 6.126

Review 5.  The liver allograft, chronic (ductopenic) rejection, and microchimerism: what can they teach us?

Authors:  A J Demetris; N Murase; C P Delaney; M Woan; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1995-02       Impact factor: 1.066

Review 6.  Autoimmune hepatitis.

Authors:  Diego Vergani; Maria Serena Longhi; Dimitrios P Bogdanos; Yun Ma; Giorgina Mieli-Vergani
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

7.  A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence.

Authors:  J-C Duclos-Vallée; M Sebagh; K Rifai; C Johanet; E Ballot; C Guettier; V Karam; M Hurtova; C Feray; M Reynes; H Bismuth; D Samuel
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

Review 8.  Drug therapy in the management of type 1 autoimmune hepatitis.

Authors:  A J Czaja
Journal:  Drugs       Date:  1999-01       Impact factor: 9.546

Review 9.  Pediatric liver transplantation.

Authors:  Marco Spada; Silvia Riva; Giuseppe Maggiore; Davide Cintorino; Bruno Gridelli
Journal:  World J Gastroenterol       Date:  2009-02-14       Impact factor: 5.742

Review 10.  Liver transplantation: current concepts.

Authors:  W J Wall
Journal:  CMAJ       Date:  1988-07-01       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.